Samsara BioCapital reported a 9.1% stake in Mineralys Therapeutics MLYS · 5,736,305 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 9.1%
Last report: No earlier report
Shares held: 5,736,305 sh
Class: Common Stock
Stock: Mineralys Therapeutics MLYS
Holder: Samsara BioCapital
Event date: 25/03/13
Filed: 25/03/17

9.1% stake

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/11~25/04/12

Samsara BioCapital's other 5% stake reports

Samsara BioCapital
5% stakePMV Pharmaceuticals
5% stake
PMV Pharmaceuticals
PMVP
9.9% stake
7,577,467 sh
9.9% stake
Filed 09/15
Samsara BioCapital
5% stakeEloxx Pharmaceuticals
5% stake
Eloxx Pharmaceuticals
ELOX
9.9% stake
403,586 sh
9.9% stake
Filed 08/14
Samsara BioCapital
5% stakeRani Therapeutics Holdings
5% stake
Rani Therapeutics Holdings
RANI
9.9% stake
11,322,961 sh
9.9% stake
Filed 05/28
Samsara BioCapital
5% stakeKalaris Therapeutics
5% stake
Kalaris Therapeutics
KLRS
54.2% stake
12,900,583 sh
54.2% stake
Filed 05/22
Samsara BioCapital
5% stakeSutro Biopharma
5% stake
Sutro Biopharma
STRO
6.4% stake
1,062,872 sh
6.4% stake
Filed 05/15